ALLIANCEBERNSTEIN L.P. - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 165 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$269,000
-8.5%
208,565
-9.8%
0.00%
Q4 2021$294,000
-42.0%
231,245
-0.6%
0.00%
Q3 2021$507,000
-46.6%
232,695
-8.2%
0.00%
Q2 2021$950,000
+31.8%
253,385
+14.5%
0.00%
Q1 2021$721,000
-4.4%
221,285
+0.1%
0.00%
Q4 2020$754,000
-25.9%
221,035
-11.4%
0.00%
-100.0%
Q3 2020$1,018,000
+23.7%
249,535
+2.4%
0.00%
Q2 2020$823,000
+43.1%
243,595
-1.3%
0.00%
Q1 2020$575,000
-10.3%
246,725
+40.2%
0.00%
Q4 2019$641,000
-55.9%
175,975
+0.4%
0.00%
-100.0%
Q3 2019$1,454,000
-14.8%
175,275
-11.6%
0.00%0.0%
Q2 2019$1,707,000
-2.5%
198,275
+21.1%
0.00%0.0%
Q1 2019$1,750,000
+22.2%
163,6750.0%0.00%0.0%
Q4 2018$1,432,000
-74.5%
163,675
-50.9%
0.00%
-75.0%
Q3 2018$5,606,000
+25.2%
333,675
+56.2%
0.00%
+33.3%
Q2 2018$4,479,000
+128.8%
213,675
+75.6%
0.00%
+200.0%
Q1 2018$1,958,000
-22.5%
121,675
-8.8%
0.00%
-50.0%
Q4 2017$2,527,000
+116.0%
133,375
+60.4%
0.00%
+100.0%
Q3 2017$1,170,000
+88.7%
83,1750.0%0.00%
Q2 2017$620,000
+14.6%
83,1750.0%0.00%
Q1 2017$541,000
+47.0%
83,1750.0%0.00%
Q4 2016$368,000
-5.2%
83,1750.0%0.00%
Q3 2016$388,000
-28.9%
83,1750.0%0.00%
Q2 2016$546,000
+13.0%
83,175
+9.5%
0.00%
Q1 2016$483,000
+5.5%
75,9750.0%0.00%
Q4 2015$458,000
+0.9%
75,9750.0%0.00%
Q3 2015$454,000
-12.7%
75,975
-0.1%
0.00%
Q2 2015$520,000
-5.1%
76,065
-15.7%
0.00%
Q1 2015$548,000
-13.3%
90,265
-1.1%
0.00%
-100.0%
Q4 2014$632,000
-27.4%
91,248
-14.8%
0.00%0.0%
Q3 2014$871,000
+0.1%
107,0480.0%0.00%0.0%
Q2 2014$870,000
+3.7%
107,0480.0%0.00%0.0%
Q1 2014$839,000
-11.5%
107,048
-0.0%
0.00%0.0%
Q4 2013$948,000
+5.5%
107,086
-0.0%
0.00%0.0%
Q3 2013$899,000
+12.5%
107,098
-0.0%
0.00%0.0%
Q2 2013$799,000107,1350.00%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Consonance Capital Management LP 2,020,583$15,053,0001.77%
Piermont Capital Management Inc. 247,882$1,847,0000.53%
BARD ASSOCIATES INC 129,380$964,0000.44%
Sonora Investment Management, LLC 239,202$1,782,055,0000.34%
TFS CAPITAL LLC 97,526$727,0000.28%
Alambic Investment Management, L.P. 165,001$1,229,0000.15%
KENNEDY CAPITAL MANAGEMENT LLC 491,075$3,659,0000.07%
Renaissance Technologies 6,071,817$45,235,0000.06%
Granite Investment Partners, LLC 97,023$723,0000.05%
ClariVest Asset Management LLC 241,909$1,802,0000.04%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders